TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 71 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $814,649 | -0.6% | 21,603 | 0.0% | 0.00% | – |
| Q2 2023 | $819,402 | +46830.2% | 21,603 | -64.1% | 0.00% | -100.0% |
| Q4 2022 | $1,746 | -99.9% | 60,137 | +9.6% | 0.00% | 0.0% |
| Q3 2022 | $1,645,000 | -15.4% | 54,845 | +2.0% | 0.00% | 0.0% |
| Q2 2022 | $1,945,000 | -19.2% | 53,780 | +0.6% | 0.00% | 0.0% |
| Q1 2022 | $2,406,000 | -7.7% | 53,461 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $2,608,000 | -35.8% | 53,461 | -14.7% | 0.00% | 0.0% |
| Q3 2021 | $4,064,000 | -1.7% | 62,679 | +9.0% | 0.00% | 0.0% |
| Q2 2021 | $4,136,000 | +3.0% | 57,484 | +5.6% | 0.00% | 0.0% |
| Q1 2021 | $4,016,000 | +279.2% | 54,460 | +277.6% | 0.00% | – |
| Q4 2020 | $1,059,000 | -63.4% | 14,424 | -28.4% | 0.00% | -100.0% |
| Q2 2015 | $2,895,000 | +5.4% | 20,149 | +3.5% | 0.02% | +6.7% |
| Q1 2015 | $2,746,000 | – | 19,472 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ISZO CAPITAL MANAGEMENT LP | 582,409 | $90,011,000 | 60.33% |
| GUARDIAN POINT CAPITAL, LP | 70,000 | $10,819,000 | 10.19% |
| Think Investments LP | 186,373 | $28,804,000 | 8.16% |
| Greywolf Capital Management LP | 277,936 | $42,955,000 | 7.45% |
| Valentine Capital Asset Management, Inc. | 28,431 | $4,394,000 | 4.91% |
| FORT, L.P. | 63,675 | $9,841,000 | 4.69% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 527,266 | $81,489,000 | 3.63% |
| RPG Investment Advisory, LLC | 60,910 | $9,413,000 | 3.52% |
| Kerrisdale Advisers, LLC | 81,996 | $12,672,000 | 3.24% |
| Strategic Global Advisors, LLC | 48,154 | $7,442,000 | 3.17% |